propranolol has been researched along with cortodoxone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Demura, H; Demura, R; Jujo, K; Maeda, T; Odagiri, E; Shizume, K; Suda, T; Takano, K | 1 |
3 other study(ies) available for propranolol and cortodoxone
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Hypothalamic-pituitary functions in patients with idiopathic pituitary dwarfism.
Topics: Adolescent; Adult; Arginine; Child; Cortodoxone; Dwarfism, Pituitary; Follicle Stimulating Hormone; Glucagon; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Hypothyroidism; Insulin; Luteinizing Hormone; Metyrapone; Pituitary Function Tests; Prolactin; Propranolol; Thyroid Function Tests; Thyrotropin; Thyrotropin-Releasing Hormone | 1975 |